These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 163142

  • 1. Advances in the treatment of Wilms' tumor.
    Wolff JA.
    Cancer; 1975 Mar; 35(3 suppl):901-4. PubMed ID: 163142
    [Abstract] [Full Text] [Related]

  • 2. Effect of postoperative chemotherapy and radiotherapy, on the survival of subcutaneously implanted Furth Wilms' tumor.
    Kedar A, McGarry M, Moore R, Williams P, Murphy GP.
    Oncology; 1981 Mar; 38(2):65-8. PubMed ID: 6258122
    [Abstract] [Full Text] [Related]

  • 3. A murine Wilms' tumor as a model for chemotherapy and radiotherapy.
    Tomashefsky P, Homsy YL, Lattimer JK, Tannenbaum M.
    J Natl Cancer Inst; 1976 Jan; 56(1):137-42. PubMed ID: 176375
    [Abstract] [Full Text] [Related]

  • 4. Management of Wilms' tumor with particular emphasis on combination treatment with radiation, actinomycin D and vincristine.
    Harrison J, Myers M, Wiley A, Vermund H.
    Int J Radiat Oncol Biol Phys; 1976 Jan; 1(3-4):227-34. PubMed ID: 184070
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of Wilms' tumor in childhood].
    Goldschmidt H, Bachmann KD.
    Dtsch Med Wochenschr; 1974 Feb; 99(8):360-3. PubMed ID: 4362671
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM, Breslow NE, Beckwith JB, Finklestein JZ, Grundy PE, Thomas PR, Kim T, Shochat SJ, Haase GM, Ritchey ML, Kelalis PP, D'Angio GJ.
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [Abstract] [Full Text] [Related]

  • 14. Proceedings: The national Wilms' tumor study: a progress report.
    D'Angio GJ, Beckwith JB, Bishop HC, Breslow N, Evans AE, Goodwin WE, King LR, Pickett LK, Sinks LF, Sutow WW.
    Proc Natl Cancer Conf; 1972 Jan; 7():627-36. PubMed ID: 4358068
    [No Abstract] [Full Text] [Related]

  • 15. Vincristine (NSC-67574) therapy for Wilms' tumor.
    Sullivan MP.
    Cancer Chemother Rep; 1968 Jun; 52(4):481-4. PubMed ID: 4317500
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Radiation related toxicities in National Wilms' Tumor Study Number 1.
    Tefft M.
    Int J Radiat Oncol Biol Phys; 1977 Jun; 2(5-6):455-63. PubMed ID: 195920
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.